Literature DB >> 11591155

Mutational effects at the subunit interfaces of human hemoglobin: evidence for a unique sensitivity of the T quaternary state to changes in the hinge region of the alpha 1 beta 2 interface.

R W Noble1, H L Hui, L D Kwiatkowski, P Paily, A DeYoung, A Wierzba, J E Colby, S Bruno, A Mozzarelli.   

Abstract

A set of variant human hemoglobins, each with an Ala or Gly substitution at a single residue, has been prepared, and the kinetics of their reactions with carbon monoxide have been measured. This reaction is rate-limited by the binding of the first CO to the deoxygenated T state of the protein. The magnitudes of the effects of the mutations on CO combination vary widely, and, with the exception of beta Y145, the residues with the most significant effects on these kinetics are found in the hinge region of the alpha 1 beta 2 interface. Mixed-metal hybrids, with zinc protoporphyrin IX in place of heme on both alpha or both beta subunits, were prepared for beta W37E, beta W37A, alpha Y140G, and alpha Y140A, hinge region variants causing large kinetic changes, and for beta Y145G. Such hybrids permit measurements of the kinetics of CO binding to only the heme-containing alpha or beta subunits within the unliganded hemoglobin tetramer. Mutations at beta 37 and alpha 140 have global effects on the T state, increasing the rates of CO binding to both types of subunits. Mutation of beta Y145 has a large effect on the beta subunits in the deoxygenated T state, but very little effect on the alpha subunits. Oxygen equilibria measurements on the crystalline T state of beta W37E also indicate large affinity increases in both subunits of this variant. The overall oxygen equilibria of the variant hemoglobins in solution are sensitive to numerous variables besides the properties of the deoxygenated T state. In contrast to CO combination kinetics, the residues whose alterations cause the largest changes in overall oxygen equilibria in solution are scattered seemingly randomly within the alpha 1 beta 2 interface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11591155     DOI: 10.1021/bi010988p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Modulation of reactivity and conformation within the T-quaternary state of human hemoglobin: the combined use of mutagenesis and sol-gel encapsulation.

Authors:  Uri Samuni; Camille J Roche; David Dantsker; Laura J Juszczak; Joel M Friedman
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

2.  A quantum-chemical picture of hemoglobin affinity.

Authors:  R E Alcantara; C Xu; T G Spiro; V Guallar
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-14       Impact factor: 11.205

3.  Interfacial and distal-heme pocket mutations exhibit additive effects on the structure and function of hemoglobin.

Authors:  David H Maillett; Virgil Simplaceanu; Tong-Jian Shen; Nancy T Ho; John S Olson; Chien Ho
Journal:  Biochemistry       Date:  2008-09-13       Impact factor: 3.162

4.  Correlation of protein functional properties in the crystal and in solution: the case study of T-state hemoglobin.

Authors:  Robert W Noble; Laura D Kwiatkowski; Hilda L Hui; Stefano Bruno; Stefano Bettati; Andrea Mozzarelli
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

5.  Kinetic-dynamic model for conformational control of an electron transfer photocycle: mixed-metal hemoglobin hybrids.

Authors:  Ami D Patel; Judith M Nocek; Brian M Hoffman
Journal:  J Phys Chem B       Date:  2008-08-21       Impact factor: 2.991

Review 6.  Crystallographic evidence for dioxygen interactions with iron proteins.

Authors:  M Arménia Carrondo; Isabel Bento; Pedro M Matias; Peter F Lindley
Journal:  J Biol Inorg Chem       Date:  2007-02-21       Impact factor: 3.862

Review 7.  From protein structure to function via single crystal optical spectroscopy.

Authors:  Luca Ronda; Stefano Bruno; Stefano Bettati; Paola Storici; Andrea Mozzarelli
Journal:  Front Mol Biosci       Date:  2015-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.